Authors:
Mardiak, J
Fuchsberger, P
Lakota, J
Salek, T
Sycova-Mila, Z
Drahokoupilova, M
Balaz, M
Koza, I
Citation: J. Mardiak et al., Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors, NEOPLASMA, 47(4), 2000, pp. 239-243
Authors:
Mardiak, J
Bohunicky, L
Chovanec, J
Salek, T
Koza, I
Citation: J. Mardiak et al., Adjuvant clodronate therapy in patients with locally advanced breast cancer - long term results of a double blind randomized trial, NEOPLASMA, 47(3), 2000, pp. 177-180
Authors:
Kremery, V
Mrazova, M
Kunova, A
Grey, E
Mardiak, J
Jurga, L
Sabo, A
Sufliarsky, J
Sevcikova, L
Sorkovska, D
West, D
Trupl, J
Novotny, J
Mateicka, F
Citation: V. Kremery et al., Nosocomial candidaemias due to species other than Candida albicans in cancer patients - Aetiology, risk factors, and outcome of 45 episodes within 10years in a single cancer institution, SUPP CARE C, 7(6), 1999, pp. 428-431
Authors:
Krcmery, V
Spanik, S
Grausova, S
Trupl, J
Krupova, I
Roidova, A
Salek, T
Sufliarsky, J
Mardiak, J
Citation: V. Krcmery et al., Candida parapsilosis fungemia in cancer patients - incidence, risk factorsand outcome, NEOPLASMA, 45(5), 1998, pp. 336-342